Magda Michna compensation by year
STAAR SURGICAL Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $492,904 | $516,819 |
| Bonus | $60,000 | $0 |
| Stock awards | $1,395,164 | $1,800,036 |
| Option awards | $348,785 | $0 |
| Non-equity incentive | $0 | $353,025 |
| Pension and deferred compensation | $0 | $0 |
| All other | $16,830 | $25,872 |
| Total | $2,313,683 | $2,695,752 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: STAAR SURGICAL CO DEF 14A filed May 4, 2026, accession 0000718937-26-000015, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 52,787 | $1,245,773 | — |
| PSU | 52,787 | $1,245,773 | — |
| RSU | 12,356 | $291,602 | — |
| RSU | 4,683 | $110,519 | — |
| Option | 3,605 | — | $67.63 |
| Option | 6,917 | — | $37.64 |
Per the Outstanding Equity Awards at Fiscal Year-End table in STAAR SURGICAL CO's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
19 Form 4 lines since the FY2025 proxy (filed May 4, 2026)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-14 | Exercise or conversion derivative | — | 5,499 | $0.00 | 5,499 |
| 2026-08-14 | Tax withholding | — | 2,797 | $26.18 | 40,802 |
| 2026-08-14 | Exercise or conversion | — | 1,100 | $26.18 | 41,343 |
| 2026-08-14 | Exercise or conversion derivative | — | 1,100 | $0.00 | 1,100 |
| 2026-08-14 | Tax withholding | — | 559 | $26.18 | 40,243 |
| 2026-08-14 | Exercise or conversion | — | 5,499 | $0.00 | 43,599 |
| 2026-05-15 | Tax withholding | — | 559 | $32.07 | 42,783 |
| 2026-05-15 | Grant or award | — | 1,100 | $0.00 | 43,342 |
The 8 most recent of 19 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments STAAR SURGICAL discloses, by trigger · FY2026| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $523,000 | $0 | $14,823 | $537,823 |
| Change in control, no termination | $0 | $2,893,667 | $0 | $2,893,667 |
| Change in control and involuntary termination | $1,046,000 | $2,893,667 | $14,823 | $3,954,490 |
Per the Potential Payments Upon Termination or Change in Control table in STAAR SURGICAL CO's FY2026 proxy. Estimates as the company printed them; a dash means it printed no figure.
STAAR SURGICAL’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Stephen Farrell | Chief Executive Officer | $7,522,385 |
| Warren Foust | President and Chief Operating Officer | $4,440,664 |
| Nathaniel Sisitsky | Chief Legal Officer and Corporate Secretary | $2,765,962 |
| Magda Michna · this page | Chief Development Officer | $2,695,752 |
| Deborah Andrews | Chief Financial Officer | $2,582,411 |
| Thomas Frinzi | Former President and Chief Executive Officer | $1,255,915 |
| Patrick Williams | Former Chief Financial Officer | $926,941 |
The full STAAR SURGICAL compensation record
free company briefThis page is one person within STAAR SURGICAL's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order STAAR SURGICAL's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are STAAR SURGICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat